<PAGE>
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): AUGUST 10, 2000
------------------
HORIZON PHARMACIES, INC.
(Exact name of Registrant as specified in its charter)
Delaware 000-22403 75-2441557
(State or other (Commission File Number) (I.R.S. Employer
jurisdiction of incorporation) Identification Number)
531 W. MAIN STREET 75020
SUITE 100 (Zip code)
DENISON, TEXAS
(Address of principal
executive offices)
Registrant's telephone number, including area code: (903) 465-2397
NOT APPLICABLE
(Former name or former address, if changed since last report)
================================================================================
<PAGE>
ITEM 5. OTHER EVENTS
On August 10, 2000, HORIZON Pharmacies, Inc. ("Horizon") announced that
it had signed an engagement letter with Southwest Securities whereby
Southwest Securities agreed to act as exclusive financial advisor to Horizon
with respect to exploring strategic alternatives involving Horizon.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) EXHIBITS.
99.1 -- August 10, 2000 Press Release
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this current report to be signed on its behalf by
the undersigned thereunto duly authorized.
HORIZON PHARMACIES, INC.
By: /s/ John N. Stogner
--------------------------------------
John N. Stogner
Chief Financial Officer
Date: August 17, 2000
<PAGE>
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT
NUMBER EXHIBIT TITLE
------ -------------
<S> <C>
99.1 -- August 10, 2000 Press Release
</TABLE>
